SCHEMBL22904576

SCHEMBL22904576

Cc1ccccc1Oc1cccc2c1C(=O)NC(=O)C2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 1/20 0.50
▸ CASP3 P42574 2/20 0.44
▸ CASP2 P42575 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ CASP6 P55212 1/20 0.44
▸ CASP8 Q14790 1/20 0.44
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ LMNA P02545 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ GSK3B P49841 3/20 0.38
▸ STK10 O94804 1/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ STK33 Q9BYT3 1/20 0.38
▸ SLK Q9H2G2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22909253 0.81 CASP3 (0.45) DAOCASP3CASP2CASP7CASP6
SCHEMBL27553346 0.80 KDM4E (0.41) DAOCASP3ALDH1A1MAPTGSK3B
SCHEMBL262473 0.78 GSK3B (0.50) CASP3CASP2CASP7CASP6CASP8
SCHEMBL22904128 0.74 TDP2 (0.51) CASP3CASP7CASP6CASP8MAPT
SCHEMBL22909125 0.72 SOD1 (0.40) CASP3MAOAMAOBLMNAALDH1A1
SCHEMBL26473527 0.72 HDAC4 (0.41) CASP3CASP2CASP7CASP6CASP8
SCHEMBL22904554 0.71 LMNA (0.44) CASP3CASP2CASP7CASP6CASP8
SCHEMBL5506330 0.71 MAOA (0.51) CASP3CASP2CASP7CASP6CASP8
SCHEMBL28756658 0.70 MAPT (0.38) DAOCASP3ALDH1A1MAPTGSK3B
SCHEMBL26454576 0.70 P2RX3 (0.36) CASP3CASP2CASP7CASP6CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 — — WO disclosed
Send feedback